Journal of Protein Chemistry

, Volume 15, Issue 4, pp 351–358 | Cite as

Human neurotrophin-3: A one-step peptide mapping method and complete disulfide characterization of the recombinant protein

  • John O. Hui
  • John Le
  • Viswanatham Katta
  • Robert Rosenfeld
  • Michael F. Rohde
  • Mitsuru Haniu
Article

Abstract

Human neurotrophin-3 (NT-3) is a member of the nerve growth factor (NGF) family of neurotrophic factors, and the recombinant protein is being developed as a therapeutic for neurodegenerative diseases. The final product purity and lot-to-lot variation are monitored routinely by peptide mapping. However, only the N-terminal region of NT-3 was susceptible to proteolysis under native conditions. Complete digestion required that the protein be chemically modified by reduction and S-alkylation prior to proteolysis. Complete proteolytic degradation of the protein was achieved simply by an intial denaturation of NT-3 in 6 M guanidinium chloride (pH 6) for 2 hr at 37°C, followed by a tenfold dilution with the digestion buffer (0.1 M Tris-HCl, 1 mM CaCl2 at pH 7.0) and immediate addition of chymotrypsin at 1% by weight. Direct comparison of the peptide map with an identical aliquot that had been reduced and alkylated also allowed the establishment of the cystine linkages present in NT-3: Cys14 to Cys79, Cys57 to Cys108, and Cys67 to Cys110. This disulfide structure is homologous to the NGF family of neurotrophic factors.

Key words

Neurotrophins peptide mapping disulfide characterization 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acklin, C., Stoney, K., Rosenfeld, R., Miller, J., Rohde, M. F., and Haniu, M. (1993).Int. J. Peptide Protein Res. 41, 548–552.Google Scholar
  2. Angeletti, R. H., and Bradshaw, R. A. (1971).Proc. Natl. Acad. Sci. USA 68, 2417–2420.PubMedGoogle Scholar
  3. Barnett, J., Chow, J., Nguyen, B., Eggers, D., Osen, E., Jarnagin, K., Saldou, N., Straub, K., Gu, L., Erdos, L., Chaing, H.-S., Fausnaugh, J., Townsend, R. R., Lile, J., Collins, F., and Chan, H. (1991).J. Neurochem. 57, 1052–1061.PubMedGoogle Scholar
  4. Bradshaw, R. A., Blundell, T. L., Lapatto, R., McDonald, N. Q., and Murray-Rust, J. (1993).Trends Biochem. Sci. 18, 48–52.PubMedGoogle Scholar
  5. Bradshaw, R. A., Murray-Rust, J., Ibanez, C. F., McDonald, N. Q., Lapatto, R., and Blundell, T. (1994).Protein Sci. 3, 1901–1913.PubMedGoogle Scholar
  6. Garnick, R. L., Solli, N. J., and Papa, P. A. (1988).Anal. Chem. 60, 2546–2557.PubMedGoogle Scholar
  7. Geisow, M. J. (1992).Trends Biotechnol. 10, 432–441.PubMedGoogle Scholar
  8. Haniu, M., Acklin, C., Kenney, W. C., and Rhode, M. F. (1994).Int. J. Peptide Protein Res. 43, 81–86.Google Scholar
  9. Hui, J. O., Meng, S.-Y., Katta, V., Rohde, M. F., Tsai, L. B., and Haniu, M. (1955). InTechniques in Protein Chemistry, Vol. VI (Crabb, J., ed.), Academic Press, San Diego, California, pp. 341–348.Google Scholar
  10. Jones, M. D., Mereweather, L., Clogston, C. L., and Lu, H. S. (1994).Anal. Biochem. 216, 135–146.PubMedGoogle Scholar
  11. Kolbeck, R., Jungbluth, S., and Barde, Y.-A. (1994).Eur. J. Biochem. 225, 995–1003.PubMedGoogle Scholar
  12. Marti, T., Rosselet, S., Titani, K., and Walsh, K. (1987).Biochemistry 26, 8099–8109.PubMedGoogle Scholar
  13. Rosenfeld, R., and Benedek, K. (1993).J. Chromatog. 632, 29–36.Google Scholar
  14. Snider, W. D. (1994).Cell 77, 627–638.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • John O. Hui
    • 1
  • John Le
    • 1
  • Viswanatham Katta
    • 1
  • Robert Rosenfeld
    • 2
  • Michael F. Rohde
    • 1
  • Mitsuru Haniu
    • 1
  1. 1.Protein StructureAmgen Inc.Thousand Oaks
  2. 2.Protein ChemistryAmgen Inc.Thousand Oaks

Personalised recommendations